Navigation Links
Bernstein Liebhard LLP Answers Stryker Hip Recall Questions, Provides Lawsuit Information on New Website
Date:10/27/2013

New York, NY (PRWEB) October 27, 2013

A new Stryker hip recall (http://www.thestrykerhiprecall.com/) website has been launched by the nationwide law firm of Bernstein Liebhard LLP to help answer the legal questions of individuals who were allegedly injured by the manufacturer’s Rejuvenate or ABG II modular-neck hip stems.

On the new website, a detailed list of side effects allegedly associated with the recalled metal implants is available, as is information regarding the legal process of filing a lawsuit over the Stryker Rejuvenate and ABG II hip replacement devices. The Firm’s new site will also include a background of the Stryker hip recall, which was issued on July 6, 2012 after the manufacturer learned of its products’ potential to fret and corrode at the modular-neck junction, which may lead to patient injury and early device failure. Stryker lawsuit claims allege the potential for pain, swelling, metallosis and other complications to stem from implantation of the Stryker Rejuvenate and/or ABG II hips.*

“Our new website will help provide answers to patients who have legal questions regarding the Stryker hip recall, and the process of filing a claim alleging pain and complications stemming from premature failure of the Rejuvenate and ABG II devices,” says Bernstein Liebhard LLP, a nationwide law firm representing individuals who were injured by defective drugs and/or medical devices. In addition to the information available on its new website, the Firm is also offering free and confidential case evaluations to potential Stryker lawsuit claimants.

Stryker Hip Recall

Since the Stryker hip recall, which affected some 20,000 Rejuvenate and ABG II devices, court records show that hundreds of individuals have come forward to file lawsuits in courts throughout the U.S. Approximately 380 claims are currently pending in a Multicounty Litigation underway in New Jersey’s Bergen County Superior Court, (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296) while another 290 cases have been filed in a federal litigation established in the U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)

In October 2013, court documents indicated that another state proceeding involving the Stryker hip recall was created in Florida’s Broward County Circuit Court. At the time of its creation, 13 lawsuits had been consolidated in the litigation after being filed by individuals who allege the Rejuvenate and ABG II implants may result in pain, swelling, metallosis and other injuries stemming from elevated levels of metal toxicity in the bloodstream. (Simon v. Howmedica Osteonics Corp.,et al., No. CACE-12-25899 (18)) In the wake of its recall, Stryker Orthopaedics has recommended on its website that all hip recipients undergo routine blood testing and cross-sectional imaging to monitor for elevated metal levels, whether or not they are experiencing symptoms of early device failure.*

If you received the Stryker Rejuvenate or ABG II hip stems, you may be entitled to compensation for the pain, suffering and other complications you may have experienced. Learn more about Stryker hip injuries by visiting Bernstein Liebhard LLP’s new website, or be contacting one of the Firm’s lawyers directly at 800-511-5092.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.thestrykerhiprecall.com/

Read the full story at http://www.prweb.com/releases/Stryker-hip-recall/Stryker-hip-lawsuit/prweb11271347.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
2. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
3. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
8. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
9. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
10. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
11. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: